Skip to main content
THQ logo

THQ

abrdn Healthcare Opportunities Fund
$18.99 -0.14 (-0.73%) At close · Jul 10
Market Cap
$786.90M
Shares
41,437,475

Price & Indicators

20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$18.99 Open$19.13 Day$18.88–19.13 52W$13.99–19.81 Avg vol 30d235K Short int422K · 1.0% float · 1.3d Short vol55% DataJan 2020–Jul 2026
Up next
FQ4-26 quarter ends
~Sep 30, 2026 Est
Equibles Rating blended score · not investment advice
Overall
Buy
SellHoldBuy
Technical Strong Buy Momentum Strong Sentiment Bullish Fundamentals Limited Quant / Vol Very Low
Market backdrop VIX 15 · calm Equity put/call 0.55
Technical
price trend
Strong Buy
50 / 200-day cross No cross
Price vs 200-day avg +3%
above
Price vs 50-day avg +3%
above
RSI (14) 56
neutral
MACD trend Positive
52-week position 86%
near high
Momentum
relative strength
Strong
1-month return +2%
trailing
6-month return −1%
trailing
YTD return +2%
this year
Relative strength −10%
vs S&P · 6-mo
Sentiment
smart money
Bullish
Trend (MA cross) No cross
50d $19 › 200d $18 — 50d above 200d
Institutional flow Accumulating
6 of 88 funds reported for Jun 30 · net +9.3K sh shares · +3 new
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
1.02% of float · ▼ -34.9% MoM · 1.3 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
88 holders — mid 3-yr range
Squeeze score 41
elevated · 0–100
Fundamentals
Limited
Not enough data for a confident read.
Quant / Vol
risk profile
Very Low
Volatility 18%
annualized · 1-yr
Max drawdown −17%
past year
ATR 1.6%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Strong Buy
0 · 2 · 4
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
+3% Bullish
Price vs 50-day avg
+3% Bullish
RSI (14)
56 Neutral
MACD trend
Positive Bullish
52-week position
86% Bullish
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross) No cross
50d $19 › 200d $18 — 50d above 200d
Institutional flow Accumulating
6 of 88 funds reported for Jun 30 · net +9.3K sh shares · +3 new
Insider flow Flat
No net insider activity over 90 days
Short interest Falling
1.02% of float · ▼ -34.9% MoM · 1.3 days cover
Volume signal Normal
Volume near normal
Institution breadth Steady
88 holders — mid 3-yr range
Price context
position in its 52-week range
52-wk low $14 Now $19 · 86% 52-wk high $20
vs 200-day avg +3% vs 50-day avg +3%

Illustrative technical + ownership context — a signal mix, not investment advice.

Versus peers

Asset Management — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
THQ
abrdn Healthcare Opportunities Fund
this stock
$786.90M +2.2% 1.0%
BLK
BlackRock, Inc.
$337.44B -2.7% +16.2% 26.1 0.6%
BN
BROOKFIELD Corp /ON/
$97.68B -4.4% 0.7%
BX
Blackstone Inc.
$91.44B -19.2% +9.2% 31.6 3.1%
KKR
KKR & Co. Inc.
$87.04B -23.8% -11.0% 1.7%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Accumulating
Holders
91
% held
18.8%
Reported
6 of 88
Top holder
MORGAN STANLEY
Held Float
View
Held by Funds
Fund positions
3
View
Short & Settlement
Short Interest Falling
Shares short
421.9K
Days to cover
1.3d
Change
-225.9K sh
View
Short Volume
Short vol %
55%
As of
Jul 10, 2026
Short Total
View
Fails to Deliver
FTD shares
203
Value
$3.8K
As of
Jun 12, 2026
View
Off-Exchange
Off-exchange %
82.8%
Week of
May 4, 2026
Off-exch Lit
View
Filings
SEC Filings
Latest
DEF 14A
Filed
Apr 7, 2026
This year
1
View

Performance

5D 20D 120D MTD YTD
THQ +0.1% +2.5% -1.2% +1.4% +2.2%
SPY +1.4% +4.1% +9.1% +1.1% +10.7%
vs SPY -1.3% -1.6% -10.3% +0.3% -8.5%

Capital returns

Latest dividend
$0.18 / share · ex Jun 23, 2026
Paid (TTM)
$2.16 / share · 12 payouts
Dividend yield (TTM, derived)
11.37%

Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

Key facts CIK 1604522 CUSIP 879105104 13F (30d) 6 filings 6 filers